Abstract
AbstractDopamine D1 receptor (D1R) is an important drug target implicated in many psychiatric and neurological disorders. Selective agonism of D1R are sought to be the therapeutic strategy for these disorders. Most selective D1R agonists share a dopamine-like catechol moiety in their molecular structure, and their therapeutic potential is therefore limited by poor pharmacological properties in vivo. Recently, a class of non-catechol D1R selective agonists with a distinct scaffold and pharmacological properties were reported. Here, we report the crystal structure of D1R in complex with stimulatory G protein (Gs) and a non-catechol agonist Compound 1 at 3.8 Å resolution. The structure reveals the ligand bound to D1R in an extended conformation, spanning from the orthosteric site to extracellular loop 2 (ECL2). Structural analysis reveals that the unique features of D1R ligand binding pocket explains the remarkable selectivity of this scaffold for D1R over other aminergic receptors, and sheds light on the mechanism for D1R activation by the non-catechol agonist.
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry
Reference76 articles.
1. Beaulieu, J. M., Espinoza, S. & Gainetdinov, R. R. Dopamine receptors—IUPHAR review 13. Br. J. Pharmacol. 172, 1–23 (2015).
2. Beaulieu, J. M. & Gainetdinov, R. R. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol. Rev. 63, 182–217 (2011).
3. Rangel-Barajas, C., Coronel, I. & Florán, B. Dopamine receptors and neurodegeneration. Aging Dis. 6, 349–349 (2015).
4. Arnsten, A. F. T., Girgis, R. R., Gray, D. L. & Mailman, R. B. Novel dopamine therapeutics for cognitive deficits in schizophrenia. Biol. Psychiatry 81, 67–77 (2017).
5. Hisahara, S. & Shimohama, S. Dopamine receptors and Parkinson’s disease. Int. J. Med. Chem. 2011, 1–16 (2011).
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献